Skip to main content
OpenTrials
Completed

NCT Number: NCT00679640

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Cohort Study Heart Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Mulhouse, Alsace, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure

Exclusion criteria

  • patients included in a clinical trial the last 30 days before consultation
  • patients unable to answer the questions for linguistic or cognitive reasons
  • patients who will be difficult to follow during the one year study

Treatment and study plan

Candesartan

Drug

Oral tablets

Other names: Atacand

Primary outcomes

  1. Profile of patients treated with candesartan for heart failure

    Time frame: At inclusion

Secondary outcomes

  1. Percentage of patients taking correctly its treatment : indication, contraindication, drug titration, treatment monitoring

    Time frame: 6 and 12 months after

  2. Percentage of patients stopping its treatment and reasons why

    Time frame: 12 months after

  3. Percentage of hospitalisations due to heart failure and cardiovascular deaths

    Time frame: 12 months after

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Collaborators

  • Takeda

Registry information

Acronym: SISTOLA

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
May 19, 2008
Registry last updated
Dec 2, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.